New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options

Franco Naccarella, Chen Liying, Gerald Naccarelli, Stefano Sdringola Maranga, Giovannina Lepera, Mauro Gatti, Stefano Pazzaglia, Giovanna Spinelli, Barbara Bresciani, Ettore Ambrosioni, Claudio Borghi, Giorgio Arpesella

Research output: Contribution to journalReview articlepeer-review

Abstract

Acutely decompensated heart failure (ADHF) represents the leading reason for hospital admissions in patients over 65 years of age. Aim of this paper is to analyze new approaches for acute heart failure treatment. Effective new treatments should be found to reduce the length of hospital stay and its correlate costs in CHF symptomatic and asymptomatic patients. According to the Authors' personal experience and new clinical data from controlled clinical trials, it is mandatory to substitute traditional inotropes, in acutely decompensated heart failure, as first option, with the advice to use alternative drugs, at least in patients with the cardio renal syndrome. The Author consider the possibility of treatment of ADHF trying toblock mainly compensatory systems and neurohermons.

Original languageEnglish (US)
Pages (from-to)7-24
Number of pages18
JournalMediterranean Journal of Pacing and Electrophysiology
Volume6
Issue number1
StatePublished - Jan 1 2004

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options'. Together they form a unique fingerprint.

Cite this